>Q9Y233_Disorder
6-90, 107-138, 151-193, 205-249, 265-275, 399-421, 448-455, 981-987
masleEPLAP RPQGPLPAAG DEPGCGPGKL RPEPRLSAAG GGSAAGPGPA PEWPGRGRAE RAAPPRPPLS SAGRPSPAGG PGALSARGGG cgwvaarapl alafssRVPS SSPSFFYFWP PPPPPPPSFL PSSSAFHLpv rlpgregaaa AAAAGGGGDA GGGGGGGQEA APLSVPTSSS HRGGGGSGGG RRRlflspal qgllLPARAG PRPPPPPRLP LGQAARRAGS PGFPGAGPGG GGQTPRRPQg asfalaaaaa llfgSDMEDG PSNNAscfrr ltecflspsl tdekvkayls lhpqvldefv sesvsaetve kwlkrknnks edesapkevs ryqdtnmqgv vyelnsyieq rldtggdnql llyelssiik iatkadgfal yflgecnnSL CIFTPPGIKE GKPRLIPAGP Itqgttvsay vaksrktllv edilgdeRFP RGTGLesgtr iqsvlclpiv taigdligil elyrhwgkea fclshqevat anlawasvai hqvqvcrgla kqtelndfll dvsktyfdni vaidsllehi miyaknlvna drcalfqvdh knkelysdlf digeekegkp vfkktkeirf siekgiagqv artgevlnip dayadprfnr evdlytgytt rnilcmpivs rgsvigvvqm vnkisgsafs ktdennfkmf avfcalalhc anmyhrirhs eciyrvtmek lsyhsictse ewqglmqftl pvrlckeiel fhfdigpfen mwpgifvymv hrscgtscfe leklcrfims vkknyrrvpy hnwkhavtva hcmyailqnn htlftdlerk glliaclchd ldhrgfsnsy lqkfdhplaa lyststmeqh hfsqtvsilq leghnifstl ssseyeqvle iirkaiiatd lalyfgnrkq leemyqtgsl nlnnqshrdr viglmmtacd lcsvtklwpv tkltandiya efwaegdemk klgiqpipmm DRDKKDEvpq gqlgfynava ipcyttltqi lpptepllka crdnlsqwek virgeetatw isspsvaqka aased
>Q9Y233_GlobDoms
250-398, 422-1053
masleeplap rpqgplpaag depgcgpgkl rpeprlsaag ggsaagpgpa pewpgrgrae raapprppls sagrpspagg pgalsarggg cgwvaarapl alafssrvps sspsffyfwp pppppppsfl psssafhlpv rlpgregaaa aaaaggggda gggggggqea aplsvptsss hrggggsggg rrrlflspal qglllparag prppppprlp lgqaarrags pgfpgagpgg ggqtprrpqG ASFALAAAAA LLFGSDMEDG PSNNASCFRR LTECFLSPSL TDEKVKAYLS LHPQVLDEFV SESVSAETVE KWLKRKNNKS EDESAPKEVS RYQDTNMQGV VYELNSYIEQ RLDTGGDNQL LLYELSSIIK IATKADGFAL YFLGECNNsl ciftppgike gkprlipagp iTQGTTVSAY VAKSRKTLLV EDILGDERFP RGTGLESGTR IQSVLCLPIV TAIGDLIGIL ELYRHWGKEA FCLSHQEVAT ANLAWASVAI HQVQVCRGLA KQTELNDFLL DVSKTYFDNI VAIDSLLEHI MIYAKNLVNA DRCALFQVDH KNKELYSDLF DIGEEKEGKP VFKKTKEIRF SIEKGIAGQV ARTGEVLNIP DAYADPRFNR EVDLYTGYTT RNILCMPIVS RGSVIGVVQM VNKISGSAFS KTDENNFKMF AVFCALALHC ANMYHRIRHS ECIYRVTMEK LSYHSICTSE EWQGLMQFTL PVRLCKEIEL FHFDIGPFEN MWPGIFVYMV HRSCGTSCFE LEKLCRFIMS VKKNYRRVPY HNWKHAVTVA HCMYAILQNN HTLFTDLERK GLLIACLCHD LDHRGFSNSY LQKFDHPLAA LYSTSTMEQH HFSQTVSILQ LEGHNIFSTL SSSEYEQVLE IIRKAIIATD LALYFGNRKQ LEEMYQTGSL NLNNQSHRDR VIGLMMTACD LCSVTKLWPV TKLTANDIYA EFWAEGDEMK KLGIQPIPMM DRDKKDEVPQ GQLGFYNAVA IPCYTTLTQI LPPTEPLLKA CRDNLSQWEK VIRGEETATW ISSPSVAQKA AASed
JOB-ID: | Q9Y233_045826Zi3Xcn8AAAEAAFtAP5wAAACX |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | Q9Y233 |
Description: | sp|Q9Y233|PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Homo sapiens OX=9606 GN=PDE10A PE=1 SV=2 |
Plot title/ID: | none |
Sequence length: | 1055 |
Download Results | smoothed raw dydx |